ExLibris header image
SFX Logo
Title: Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation
Source:

Science [0036-8075] Wang, J yr:1996


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Vogelstein, Bert, B. "Surfing the p53 network." Nature 408.6810 (2000): 307-10. Link to Full Text for this item Link to SFX for this item
2. Koshland, Daniel E E. "Crazy, but correct." Nature 432.7016 (2004): 447-447. Link to Full Text for this item Link to SFX for this item
3. Vousden, Karen H H. "Live or let die: the cell's response to p53." Nature reviews. Cancer 2.8 (2002): 594-604. Link to Full Text for this item Link to SFX for this item
4. Vousden, Karen H H. "p53 in health and disease." Nature reviews. Molecular cell biology 8.4 (2007): 275-83. Link to Full Text for this item Link to SFX for this item
5. Levine, A J J. "p53, the cellular gatekeeper for growth and division." Cell 88.3 (1997): 323-31. Link to SFX for this item
6. Hollstein, M. "p53 mutations in human cancers." Science 253.5015: 49-53. Link to SFX for this item
7. Boehr, David D D. "Biochemistry. How do proteins interact?" Science 320.5882 (2008): 1429-30. Link to SFX for this item
8. Wilson, Douglas P. "Structure-Based Optimization of Protein Tyrosine Phosphatase 1B Inhibitors: From the Active Site to the Second Phosphotyrosine Binding Site." Journal of medicinal chemistry 50.19 (2007): 4681-98. Link to Full Text for this item Link to SFX for this item
9. Clackson, T. "A hot spot of binding energy in a hormone-receptor interface." Science 267.5196 (1994): 383-6. Link to SFX for this item
10. GUNASEKARAN, K. "How different are structurally flexible and rigid binding sites? Sequence and structural features discriminating proteins that do and do not undergo conformational change upon ligand binding." Journal of molecular biology 365.1 (2007): 257-273. Link to SFX for this item
11. Goldbeter A, A. "An amplified sensitivity arising from covalent modification in biological systems." Proceedings of the National Academy of Sciences of the United States of America 78.11 (1981): 6840-6844. Link to Full Text for this item Link to SFX for this item
12. Yu, E. "Propagating conformational changes over long (and short) distances in proteins." Proceedings of the National Academy of Sciences of the United States of America 98.17 (2001): 9517-9520. Link to Full Text for this item Link to SFX for this item
13. Vousden, Karen H H. "P53 and prognosis: new insights and further complexity." Cell 120.1 (2004): 7-10. Link to SFX for this item
14. LEVINE, A. "THE P53 TUMOR SUPPRESSOR GENE." Nature 351.6326 (1991): 453-456. Link to Full Text for this item Link to SFX for this item
15. Levine, Philip W J. "P53 is a tumor suppressor gene." Cell 116.2 Suppl (2004): 67-9. Link to SFX for this item
16. Finlay, C A A. "The p53 tumour suppressor gene." Nature 351.6326 (1991): 453-6. Link to Full Text for this item Link to SFX for this item
17. Vogelstein, B. "Cancer. A deadly inheritance." Nature 348.6303 (1990): 681-682. Link to Full Text for this item Link to SFX for this item
18. Kim, William Y Y. "The regulation of INK4/ARF in cancer and aging." Cell 127.2 (2006): 265-75. Link to SFX for this item
19. Sherr, Charles J. "Cancer Cell Cycles." Science 274.5293 (1996): 1672-1677. Link to SFX for this item
20. LANE, D P P. "CANCER - P53, GUARDIAN OF THE GENOME." Nature 358.6381 (1992): 15-16. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced